Part 3 Country Profiles; Core and Optional Indicators
PLOS ONE | www.plosone.org 1
January 2014 | Volume 9 | Issue 1 | e86616
PLOS ONE | DOI:10.1371/journal.pone.0144057 December 14, 2015
لإسعافات الأولية النفسية: دليل العاملين في الميدان
This guide covers psychological first aid which involves humane, supportive and practical help to fellow human beings suffering serious crisis events. It is written for people in a position to help other...s who have experienced an extremely distressing event. It gives a framework for supporting people in ways that respect their dignity, culture and abilitiies.
more
Country Progress Report January 2008 - December 2009
This guideline document lays out the indicators for monitoring the 2016 Political Declaration on ending AIDS. The Global AIDS Monitoring (GAM) process has been often referenced as a benchmark for successful international accountability mechanisms.
This brief document compiles existing material related to mental health and psychosocial support (MHPSS) for the COVID-19 crisis, as well as other resources that can be applicable to the context. Documents are divided into different sections, based on the ‘’spaces of new vulnerability” inheren...t to some IOM programmes although many of them are applicable to other areas. They cover both mainstreaming of MHPSS and specific actions.
MHPSS managers will also find guidance on how to address the less technical and more managerial and programmatic issues related with the pandemic, including programme redefinition, surge capacity and how to manage demands to provide staff support to colleagues in the same missions
more
These guidelines were developed as part of Kenya's fast-track plan to end AIDS among adolescents and young people. Based on research into adolescent and young key populations in Kenya and elsewhere, they outline a package of HIV prevention services, and emphasize the need to combine biobehavioural i...nterventions with services in education, job skills training, mental health, and social care and protection.
more
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist national medicines regulatory authorities to... understand the nature and extent of oxytocin quality issues and to provide key technical information and quality requirements for oxytocin products in dossier assessments. Furthermore, this document also presents recommendations on other regulatory actions needed to ensure that only quality-assured oxytocin products are authorized and made available to women.
more